Aratana Therapeutics
PETX
PETX was delisted on the 17th of July, 2019.
103 hedge funds and large institutions have $280M invested in Aratana Therapeutics in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 27 reducing their positions, and 10 closing their positions.
1,283% more call options, than puts
Call options by funds: $166K | Put options by funds: $12K
174% more capital inflows, than outflows
Capital inflows: $127M | Capital outflows: $46.3M
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
67% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 27
13.44% more ownership
Funds ownership: 81.22% → 94.66% (+13%)
12% more funds holding
Funds holding: 92 → 103 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$31M |
| 2 |
Waddell & Reed Financial
Overland Park,
Kansas
|
+$17M |
| 3 |
Jennison Associates
New York
|
+$12.1M |
| 4 |
Putnam Investments
Boston,
Massachusetts
|
+$11.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPM Asset Management
Boston,
Massachusetts
|
-$16.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.92M |
| 3 |
Sio Capital Management
New York
|
-$4.48M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$3.02M |
| 5 |
Hutchin Hill Capital
New York
|
-$2.99M |
PETX Hedge Fund Activity: Q3 2015 in Review
103 of the 3,589 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics (PETX) for Q3 2015, worth a combined $280M — down 35% from $429M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PETX positions and 10 closed out — a net gain of 11 holders — while 45 added to existing stakes and 27 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $31M. The largest seller was MPM Asset Management, cutting an estimated $16.9M.
- 103 institutional investors held Aratana Therapeutics (PETX) as of Q3 2015, up from 92 in Q2 2015.
- Funds reported $280M of Aratana Therapeutics stock for Q3 2015, down 35% quarter-over-quarter.
- 21 funds opened new Aratana Therapeutics positions in Q3 2015 and 10 closed out, a net change of +11 holders.
- The largest Aratana Therapeutics buyer in Q3 2015 was Wellington Management Group, an estimated $31M added.
- The largest Aratana Therapeutics seller in Q3 2015 was MPM Asset Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q3 2015.